GlassScriptPhysician profile
Tara L Anderson
NPI 1891781035
$1,981.30
in general payments reported to CMS, 2019-2025
31 companies · $16.00 in 2025
The $16.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $363 · 2021: $311 · 2022: $366 · 2023: $377 · 2024: $126 · 2025: $16.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.13 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Intuitive Surgical, INC. | $250.00 | 2020 | |
| Hologic Sales and Service, LLC | $163.92 | 2019-2025 | Aptima, Coolseal Generator, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $120.51 | 2021-2022 | |
| Astellas Pharma US INC | $111.23 | 2019-2024 | Veozah |
| Agile Therapeutics, INC. | $107.41 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $107.10 | 2019-2022 | |
| Organon LLC | $74.25 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $69.19 | 2019 | |
| Coopersurgical, INC. | $62.50 | 2019-2022 | |
| Lilly USA, LLC | $59.25 | 2021 | |
| Sumitomo Pharma America, INC. | $58.68 | 2023 | Myfembree |
| Pfizer INC. | $58.64 | 2019-2022 | |
| Aspira Women'S Health INC | $49.15 | 2021-2022 | |
| Shield Therapeutics INC | $49.10 | 2023-2024 | Accrufer |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $39.31 | 2023-2024 | |
| Scynexis, INC. | $27.39 | 2022 | |
| Merck Sharp & Dohme LLC | $27.17 | 2019 | |
| Allergan, INC. | $25.54 | 2019 | |
| Daiichi Sankyo INC. | $24.07 | 2020 | |
| Amgen INC. | $19.68 | 2020 | |
| Ironwood Pharmaceuticals, INC | $17.80 | 2019 | |
| Dysis Medical, INC. | $16.87 | 2020 | |
| Boston Scientific Corporation | $15.07 | 2019 | |
| Duchesnay USA Incorporated | $14.89 | 2019 | |
| Meditrina | $14.89 | 2023 | |
| Covidien LP | $14.69 | 2019 | |
| Lupin INC. | $13.41 | 2019 | |
| Mission Pharmacal Company | $13.16 | 2020 | |
| Evofem Biosciences, INC. | $12.84 | 2022 | |
| Avion Pharmaceuticals | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.